Abstract
Mammalian target of rapamycin (mTOR) activity is required for memory and is dysregulated in disease. Activation of mTOR promotes protein synthesis; however, new studies are demonstrating that mTOR activity also represses the translation of mRNAs. Almost three decades ago, Kandel and colleagues hypothesised that memory was due to the induction of positive regulators and removal of negative constraints. Are these negative constraints repressed mRNAs that code for proteins that block memory formation? Herein, we will discuss the mRNAs coded by putative memory suppressors, how activation/inactivation of mTOR repress protein expression at the synapse, how mTOR activity regulates RNA binding proteins, mRNA stability, and translation, and what the possible implications of mRNA repression are to memory and neurodegenerative disorders.
| Original language | English |
|---|---|
| Pages (from-to) | 1540-1554 |
| Number of pages | 15 |
| Journal | FEBS Letters |
| Volume | 591 |
| Issue number | 11 |
| DOIs | |
| State | Published - Jun 1 2017 |
Keywords
- local translation
- mammalian target of rapamycin
- mRNA
Fingerprint
Dive into the research topics of 'mTOR referees memory and disease through mRNA repression and competition'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver